Protein kinase C modulates insulin action in human skeletal muscle.

There is good evidence from cell lines and rodents that elevated protein kinase C (PKC) overexpression/activity causes insulin resistance. Therefore, the present study determined the effects of PKC activation/inhibition on insulin-mediated glucose transport in incubated human skeletal muscle and primary adipocytes to discern a potential role for PKC in insulin action. Rectus abdominus muscle strips or adipocytes from obese, insulin-resistant, and insulin-sensitive patients were incubated in vitro under basal and insulin (100 nM)-stimulated conditions in the presence of GF 109203X (GF), a PKC inhibitor, or 12-deoxyphorbol 13-phenylacetate 20-acetate (dPPA), a PKC activator. PKC inhibition had no effect on basal glucose transport. GF increased (P < 0.05) insulin-stimulated 2-deoxyglucose (2-DOG) transport approximately twofold above basal. GF plus insulin also increased (P < 0.05) insulin receptor tyrosine phosphorylation 48% and phosphatidylinositol 3-kinase (PI 3-kinase) activity approximately 50% (P < 0.05) vs. insulin treatment alone. Similar results for GF on glucose uptake were observed in human primary adipocytes. Further support for the hypothesis that elevated PKC activity is related to insulin resistance comes from the finding that PKC activation by dPPA was associated with a 40% decrease (P < 0.05) in insulin-stimulated 2-DOG transport. Incubation of insulin-sensitive muscles with GF also resulted in enhanced insulin action ( approximately 3-fold above basal). These data demonstrate that certain PKC inhibitors augment insulin-mediated glucose uptake and suggest that PKC may modulate insulin action in human skeletal muscle.

[1]  G. Shulman,et al.  Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.

[2]  R. Donnelly,et al.  MECHANISMS OF INSULIN RESISTANCE AND NEW PHARMACOLOGICAL APPROACHES TO METABOLISM AND DIABETIC COMPLICATIONS , 1998, Clinical and experimental pharmacology & physiology.

[3]  E. Kraegen,et al.  Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. , 1997, American journal of physiology. Endocrinology and metabolism.

[4]  J. Corbett,et al.  Phorbol esters stimulate muscle glucose transport by a mechanism distinct from the insulin and hypoxia pathways. , 1997, The American journal of physiology.

[5]  R. Farese,et al.  Chronic Activation of Protein Kinase C in Soleus Muscles and Other Tissues of Insulin-Resistant Type II diabetic Goto-Kakizaki (GK), Obese/Aged, and Obese/Zucker Rats: A Mechanism For Inhibiting Glycogen Synthesis , 1996, Diabetes.

[6]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[7]  F. Liu,et al.  Activation of Protein Kinase Cα Inhibits Signaling by Members of the Insulin Receptor Family (*) , 1995, The Journal of Biological Chemistry.

[8]  A. Dunaif,et al.  Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. , 1995, The Journal of clinical investigation.

[9]  G. Dohm,et al.  Hypoxia Stimulates Glucose Transport in Insulin-Resistant Human Skeletal Muscle , 1995, Diabetes.

[10]  R. Considine,et al.  Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. , 1995, The Journal of clinical investigation.

[11]  G. Dohm,et al.  Okadaic Acid, Vanadate, and Phenylarsine Oxide Stimulate 2-Deoxyglucose Transport in Insulin-Resistant Human Skeletal Muscle , 1995, Diabetes.

[12]  F. Giorgino,et al.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. , 1995, The Journal of clinical investigation.

[13]  E. Van Obberghen,et al.  Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. , 1995, The American journal of physiology.

[14]  G. Reaven,et al.  Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. , 1994, Endocrinology.

[15]  K. Siddle,et al.  Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation. , 1994, The Biochemical journal.

[16]  S. Sanderson,et al.  Phorbol ester stimulates phosphorylation on serine 1327 of the human insulin receptor. , 1994, The Journal of biological chemistry.

[17]  R. Roth,et al.  Identification of serines‐1035/1037 in the kinase domain of the insulin receptor as protein kinase Cα mediated phosphorylation sites , 1994, FEBS letters.

[18]  M. White,et al.  Characterization of phorbol ester-stimulated serine phosphorylation of the human insulin receptor. , 1994, The Biochemical journal.

[19]  N. Ruderman,et al.  The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. , 1994, The Journal of biological chemistry.

[20]  J. Friedman,et al.  Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. , 1994, Metabolism: clinical and experimental.

[21]  G. Dohm,et al.  Effect of Moderate Obesity on Glucose Transport in Human Muscle , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  F. Marks,et al.  Rottlerin, a novel protein kinase inhibitor. , 1994, Biochemical and biophysical research communications.

[23]  E. Van Obberghen,et al.  Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. , 1994, The Journal of biological chemistry.

[24]  H. Häring,et al.  Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. , 1994, The Journal of biological chemistry.

[25]  P. Pilch,et al.  The insulin receptor: structure, function, and signaling. , 1994, The American journal of physiology.

[26]  R A Roth,et al.  Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. , 1994, Molecular endocrinology.

[27]  J. Watson,et al.  Decreased expression of protein kinase-C alpha, beta, and epsilon in soleus muscle of Zucker obese (fa/fa) rats. , 1993, Endocrinology.

[28]  K. Alberti,et al.  Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance? , 1993, Journal of internal medicine.

[29]  R. Considine,et al.  Protein kinase C: Mediator or inhibitor of insulin action? , 1993, Journal of cellular biochemistry.

[30]  J. Tavaré,et al.  Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. , 1993, The Journal of biological chemistry.

[31]  H. Klein,et al.  Insulin-mimetic actions of phorbol ester in cultured adult rat hepatocytes. Lack of phorbol-ester-elicited inhibition of the insulin signal. , 1993, The Biochemical journal.

[32]  G. J. Sale.  Serine/threonine kinases and tyrosine phosphatases that act on the insulin receptor. , 1992, Biochemical Society transactions.

[33]  J. Olefsky,et al.  Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors. , 1991, The Journal of biological chemistry.

[34]  H. Häring,et al.  Prevention by Protein Kinase C Inhibitors of Glucose-Induced Insulin-Receptor Tyrosine Kinase Resistance in Rat Fat Cells , 1991, Diabetes.

[35]  H. Coste,et al.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.

[36]  N. Ruderman,et al.  Diacylglycerol-protein kinase C signalling in skeletal muscle: a possible link to insulin resistance. , 1991, Transactions of the Association of American Physicians.

[37]  M. White,et al.  A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. , 1989, The Journal of biological chemistry.

[38]  G. Dohm,et al.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. , 1988, The Journal of clinical investigation.

[39]  C. Kahn,et al.  Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. , 1988, The Journal of biological chemistry.

[40]  D. Smith,et al.  Two systems in vitro that show insulin-stimulated serine kinase activity towards the insulin receptor. , 1988, The Biochemical journal.

[41]  W. Pories,et al.  Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes. , 1987, The Journal of clinical investigation.

[42]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[43]  O. Rosen,et al.  Increasing the cAMP content of IM-9 cells alters the phosphorylation state and protein kinase activity of the insulin receptor. , 1986, The Journal of biological chemistry.

[44]  G. Reaven,et al.  In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. , 1983, The Journal of clinical investigation.